Janssen Pharmaceutical K.k.

This study tested teclistamab, a drug that helps the immune system find and attack myeloma cells, in 40 Japanese patients whose multiple myeloma had returned or stopped responding to treatment. The goal was to check safety and find the right dose in phase 1, then see how well it …

This early-phase study tested a new drug called JNJ-64407564 in 15 Japanese patients with multiple myeloma that had come back or stopped responding to other treatments. The drug is a bispecific antibody designed to help the immune system attack cancer cells. The main goal was to …

This study tested a medicine called macitentan in 7 Japanese children (ages 3 months to 15 years) with pulmonary arterial hypertension, a condition where blood pressure in the lungs is too high. The goal was to see if the drug improves blood flow through the lungs after 24 weeks.…

This study tested whether adding bedaquiline to two standard antibiotics (clarithromycin and ethambutol) helps clear a stubborn lung infection called MAC lung disease. 129 adults who had not responded to previous treatment took part. The main goal was to see if the new combinatio…

This study followed nearly 1,000 men in Japan with high-risk prostate cancer that had spread but had not yet received hormone therapy. Researchers tracked how well treatments worked in everyday medical practice, including PSA levels, survival, and quality of life. The goal was to…

This study looked at how people with palmoplantar pustulosis (PPP) in Japan are treated. Researchers tracked 276 patients to see which systemic therapies they used and how long they stayed on them. The goal was to understand real-world treatment patterns and outcomes, not to test…